JENNA STUMP: Open Payments
NPI 1710119847 · KINGSLEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 26 payments from 7 companies in 2025. Trend: 2023 $600 · 2024 $1,053 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $187 |
| Novo Nordisk Inc | 5 | $182 |
| AstraZeneca Pharmaceuticals LP | 2 | $145 |
| Braeburn Inc. | 1 | $120 |
| Astellas Pharma US Inc | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $19 |
Products named: Wegovy, BREZTRI, BRIXADI, QULIPTA, UBRELVY, VRAYLAR, Ozempic, Veozah.
Industry payments across MI — which companies pay providers there.
